"Neuropsychological Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury.
| Descriptor ID |
D009483
|
| MeSH Number(s) |
F04.711.513
|
| Concept/Terms |
Neuropsychological Tests- Neuropsychological Tests
- Neuropsychologic Tests
- Neuropsychologic Test
- Tests, Neuropsychological
- Neuropsychological Test
- Test, Neuropsychological
|
Below are MeSH descriptors whose meaning is more general than "Neuropsychological Tests".
Below are MeSH descriptors whose meaning is more specific than "Neuropsychological Tests".
This graph shows the total number of publications written about "Neuropsychological Tests" by people in this website by year, and whether "Neuropsychological Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 5 | 8 |
| 1997 | 0 | 6 | 6 |
| 1998 | 2 | 2 | 4 |
| 1999 | 1 | 2 | 3 |
| 2000 | 2 | 1 | 3 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 6 | 6 |
| 2003 | 1 | 7 | 8 |
| 2004 | 2 | 5 | 7 |
| 2005 | 3 | 7 | 10 |
| 2006 | 1 | 10 | 11 |
| 2007 | 0 | 10 | 10 |
| 2008 | 2 | 7 | 9 |
| 2009 | 1 | 23 | 24 |
| 2010 | 3 | 19 | 22 |
| 2011 | 3 | 24 | 27 |
| 2012 | 3 | 19 | 22 |
| 2013 | 4 | 26 | 30 |
| 2014 | 1 | 26 | 27 |
| 2015 | 4 | 28 | 32 |
| 2016 | 0 | 30 | 30 |
| 2017 | 0 | 15 | 15 |
| 2018 | 1 | 25 | 26 |
| 2019 | 2 | 6 | 8 |
| 2020 | 5 | 18 | 23 |
| 2021 | 2 | 14 | 16 |
| 2022 | 0 | 12 | 12 |
| 2023 | 1 | 11 | 12 |
| 2024 | 1 | 14 | 15 |
| 2025 | 2 | 6 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neuropsychological Tests" by people in Profiles.
-
Comprehensive Neuropsychological Assessment of Confirmed Xeroderma Pigmentosum a Variant with Neurological Manifestations: Case Report. Arch Clin Neuropsychol. 2025 Oct 19; 40(7):1427-1434.
-
Language impairment is associated with faster progression in progressive supranuclear palsy-Richardson syndrome. Alzheimers Dement. 2025 Jul; 21(7):e70485.
-
Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia. Alzheimers Dement. 2025 Apr; 21(4):e14608.
-
White Matter, Cognition, and Electrophysiological Variables in Bipolar Disorder: Using Multimodal Integration of Biomarker Variables Associated With Bipolar Disorder to Elucidate Deficits. Bipolar Disord. 2025 May; 27(3):205-216.
-
Amyloid PET predicts longitudinal functional and cognitive trajectories in a heterogeneous cohort. Alzheimers Dement. 2025 Mar; 21(3):e70075.
-
Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials. J Prev Alzheimers Dis. 2025 Apr; 12(4):100075.
-
Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer's disease: a neuropsychological data-driven approach. Alzheimers Res Ther. 2025 Feb 06; 17(1):38.
-
Identifying mild traumatic brain injury in the post-acute polytrauma setting: a scoping review of diagnostic approaches and screening tools. Brain Inj. 2025 May 12; 39(6):445-456.
-
Differences in baseline cognitive performance between participants with early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI. Alzheimers Dement. 2025 Jan; 21(1):e14218.
-
Longitudinal cognitive performance of participants with sporadic early onset Alzheimer's disease from LEADS. Alzheimers Dement. 2025 Feb; 21(2):e14439.